Evaluating MannKind (MNKD) Valuation After Recent Share Price Swings And Long Term Return Profile [Yahoo! Finance]
MannKind Corporation (MNKD)
Last mannkind corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.mannkindcorp.com/press-releases
Company Research
Source: Yahoo! Finance
See our latest analysis for MannKind. Recent trading has been choppy, with a 1 day share price return of a 0.53% decline at a latest share price of $5.61 and a 7 day share price return of a 4.10% decline. The 1 year total shareholder return of a 7.58% decline contrasts with a 3 year total shareholder return of 23.03% and a 5 year total shareholder return of 74.77%, which indicates that long term holders have seen stronger results than recent movers. If MannKind has you looking more closely at healthcare, this could be a good moment to scan for other treatment focused names using our screener for healthcare stocks So with MannKind trading around $5.61, solid recent revenue and net income growth, and a sizeable gap to the average analyst price target, are you looking at an undervalued healthcare name, or is the market already pricing in future growth? With MannKind last closing at $5.61 against a narrative fair value of $9.61, the current share price sits well below that centra
Show less
Read more
Impact Snapshot
Event Time:
MNKD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNKD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNKD alerts
High impacting MannKind Corporation news events
Weekly update
A roundup of the hottest topics
MNKD
News
- MannKind (NASDAQ:MNKD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- MannKind Provides Business Updates and 2026 Growth Drivers [Yahoo! Finance]Yahoo! Finance
- MannKind (NASDAQ:MNKD) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- MannKind Provides Business Updates and 2026 Growth DriversGlobeNewswire
- MannKind Corporation (MNKD) Secures FDA Approval for FUROSCIX Pediatric Use, Expanding Reach In Heart, Kidney Disease Care [Yahoo! Finance]Yahoo! Finance
MNKD
Earnings
- 11/5/25 - Beat
MNKD
Sec Filings
- 1/9/26 - Form 4
- 1/8/26 - Form 144
- 12/29/25 - Form 4
- MNKD's page on the SEC website